Firazorexton () is an
experimental orexin 2 (OX2) receptor agonist
An agonist is a chemical that activates a receptor to produce a biological response. Receptors are cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast, an antagonist blocks the action of the ago ...
first described in a 2019
patent filed by
Takeda Pharmaceutical Company.
See also
*
Orexin receptor § Agonists
*
List of investigational sleep drugs § Orexin receptor agonists
References
Alcohols
Experimental drugs
Fluoroarenes
Orexin receptor agonists
Pyrrolidines
Sulfonamides
{{Nervous-system-drug-stub